Dihydroxyacetone phosphate accumulation leads to podocyte pyroptosis in diabetic kidney disease
Journal of Cellular and Molecular Medicine · 2024-02 · 28 (3)
DOI: 10.1111/jcmm.18073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 08.12.2023. Verfasst von Zongwei Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Podocytes, Diabetes Mellitus. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Diabetic kidney disease (DKD) can lead to accumulation of glucose upstream metabolites due to dysfunctional glycolysis. But the effects of accumulated glycolysis metabolites on podocytes in DKD remain unknown. The present study examined the effect of dihydroxyacetone phosphate (DHAP) on high glucose induced podocyte pyroptosis. By metabolomics, levels of DHAP, GAP, glucose‐6‐phosphate and fructose 1, 6‐bisphosphate were significantly increased in glomeruli of db/db mice. Furthermore, the expression of LDHA and PKM2 were decreased. mRNA sequencing showed upregulation of pyroptosis‐related genes ( Nlrp3 , Casp1 , etc.). Targeted metabolomics demonstrated higher level of DHAP in HG‐treated podocytes. In vitro, ALDOB expression in HG‐treated podocytes was significantly increased. siALDOB‐transfected podocytes showed less DHAP level, mTORC1 activation, reactive oxygen species (ROS) production, and pyroptosis, while overexpression of ALDOB had opposite effects. Furthermore, GAP had no effect on mTORC1 activation, and mTORC1 inhibitor rapamycin alleviated ROS production and pyroptosis in HG‐stimulated podocytes. Our findings demonstrate that DHAP represents a critical metabolic product for pyroptosis in HG‐stimulated podocytes through regulation of mTORC1 pathway. In addition, the results provide evidence that podocyte injury in DKD may be treated by reducing DHAP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China.
- Nephrology and Urology Research Institute of Wuhan University, Wuhan, China.
- Department of Nephrology, The Central Hospital of Wuhan, Wuhan, China.
- Qianjiang Hospital Affiliated to Renmin Hospital of Wuhan University, Qianjiang, China.
- Qianjiang Clinical Medical College, Health Science Center, Yangtze University, Qianjiang, China.
ORCID-Profile: Wei Liang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
Zitieren
APA
Zhang, Z., Hu, H., Luo, Q., Yang, K., Zou, Z., Shi, M., & Liang, W. (2024). Dihydroxyacetone phosphate accumulation leads to podocyte pyroptosis in diabetic kidney disease. Journal of Cellular and Molecular Medicine, 28(3). https://doi.org/10.1111/jcmm.18073
Vancouver
Zhang Z, Hu H, Luo Q, Yang K, Zou Z, Shi M, et al. Dihydroxyacetone phosphate accumulation leads to podocyte pyroptosis in diabetic kidney disease. Journal of Cellular and Molecular Medicine. 2024;28(3). doi:10.1111/jcmm.18073
BibTeX
@article{Zhang2024,
author = {Zhang, Zongwei and Hu, Hongtu and Luo, Qiang and Yang, Keju and Zou, Zhengping and Shi, Ming and Liang, Wei},
title = {Dihydroxyacetone phosphate accumulation leads to podocyte pyroptosis in diabetic kidney disease},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {3},
doi = {10.1111/jcmm.18073}
}
EUVIMED